微小RNA-214在宫颈癌中的研究进展
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Research progress of microRNA-214 in the cervical cancer
  • 作者:张禹 ; 杨宏英 ; 姚宇峰 ; 李传印
  • 英文作者:ZHANG Yu;YANG Hong-ying;YAO Yu-feng;LI Chuan-yin;Institute of Medical Biology,Chinese Academy of Medical Sciences & Peking Union Medical College;Department of Gynecology of The Third Affiliated Hospital of Kunming Medical University;
  • 关键词:宫颈癌 ; miR-214 ; 异常表达
  • 英文关键词:Cervical cancer;;miR-214;;Abnormal expression
  • 中文刊名:JLYB
  • 英文刊名:Journal of Medical Postgraduates
  • 机构:中国医学科学院&北京协和医学院医学生物学研究所;昆明医科大学第三附属医院妇科;
  • 出版日期:2017-01-12 15:31
  • 出版单位:医学研究生学报
  • 年:2017
  • 期:v.30;No.237
  • 基金:国家自然科学基金(31270030,81573206);; 云南省科技厅-昆明医科大学应用基础研究联合专项(2013FB169);; 云南省医疗卫生单位内设研究机构科研项目(2014NS032)
  • 语种:中文;
  • 页:JLYB201701022
  • 页数:4
  • CN:01
  • ISSN:32-1574/R
  • 分类号:110-113
摘要
微小RNA(miRNA)可在转录后水平调控肿瘤相关基因的表达,从而在肿瘤发生发展等过程中发挥重要作用。研究显示,miR-214在宫颈癌细胞中表达异常,并可通过与多种宫颈癌相关基因(包括Plexin-B1、GALNT7以及TFAM等)的相互作用抑制宫颈癌细胞的增殖、迁移、侵袭能力,促进宫颈癌细胞的凋亡。文中就近年来有关miR-214在宫颈癌中的研究进展进行综述,以期探索miR-214与宫颈癌发生发展之间的关系,并为宫颈癌的临床诊断和治疗提供新的思路。
        MicroRNAs( miRNAs) play important roles in the processes of the occurrence and development of cancers,through regulating tumor related gene expression at post-transcription. It has shown that the expression of miR-214 is aberrant in cervical cancer. Also,miR-214 could affect the proliferation,migration,invasion and apoptosis of tumor cells by targeting various genes. This article focuses on the studies of miR-214 function in cervical cancer,and will provide a novel approach for the clinical diagnosis and the treatment of cervical cancer.
引文
[1]Torre LA,Bray F,Siegel RL,et al.Global cancer statistics,2012[J].CA Cancer J Clin,2015,65(2):87-108.
    [2]Campos-Viguri GE,Jimenez-Wences H,Peralta-Zaragoza O,et al.miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer[J].Infect Agent Cancer,2015,10:42.
    [3]Peralta-Zaragoza O,Deas J,Meneses-Acosta A,et al.Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells[J].BMC Cancer,2016,16(1):215.
    [4]Pillai RS,Bhattacharyya SN,Filipowicz W,et al.Repression of protein synthesis by miRNAs:how many mechanisms?[J]Trends Cell Biol,2007,17(3):118-126.
    [5]Wu L,Fan J,Belasco JG,et al.MicroRNAs direct rapid deadenylation of mRNA[J].Proc Natl Acad Sci USA,2006,103(11):4034-4039.
    [6]Zhou H,Yang YH,Basile JR,et al.The Semaphorin 4D-Plexin-B1-Rho A signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4[J].Angiogenesis,2014,17(1):1-14.
    [7]Peng RQ,Wan HY,Li HF,et al.MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7[J].J Biol Chem,2012,287(17):14301-14309.
    [8]Ding X,Qiu L,Zhang L,et al.The role of semaphorin 4D as a potential biomarker for antiangiogenic therapy in colorectal cancer[J].Onco Targets Ther,2016,9:1189-1204.
    [9]Hofmann BT,Schlüter L,Lange P,et al.COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer[J].Mol Cancer,2015,14(1):1-15.
    [10]Nie GH,Luo L,Duan HF,et al.GALNT7,a target of miR-494,participates in the oncogenesis of nasopharyngeal carcinoma[J].Tumour Biol,2016,37(4):1-9.
    [11]Xie D,Wu X,Lan L,et al.Downregulation of TFAM inhibits the tumorigenesis of non-small cell lung cancer by activating ROS-mediated JNK/p38MAPK signaling and reducing cellular bioenergetics[J].Oncotarget,2016,7(10):11609-11624.
    [12]Tie J,Desai J.Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system[J].Crit Rev Oncog,2012,17(1):51-67.
    [13]Basile JR,Barac A,Zhu T,et al.Class IV semaphorins promote angiogenesis by stimulating Rho-initiated pathways through plexin-B[J].Cancer Res,2004,64(15):5212-5224.
    [14]Qiang R,Wang F,Shi LY,et al.Plexin-B1 is a target of miR-214 in cervical cancer and promotes the growth and invasion of He La cells[J].Int J Biochem Cell Biol,2011(43):632-641.
    [15]Hua S,Saunders M,Dimapasoc LM,et al.Differentiation of cancer cell origin and molecular subtype by plasma membrane N-glycan profiling[J].J Proteome Res,2014,13(2):961-968.
    [16]Casey RC,Oegema TR,Jr,Skubitz KM,et al.Cell membrane glycosylation mediates the adhesion,migration,and invasion of ovarian carcinoma cells[J].Clin Exp Metastasis,2003,20(2):143-152.
    [17]Vojta A,Samarzija I,Bockor L,et al.Glyco-genes change expression in cancer through aberrant methylation[J].Biochim Biophys Acta,2016,1860(8):1776-1785.
    [18]Garstka HL,Schmitt WE,Schultz J,et al.Import of mitochondrial transcription factor A(TFAM)into rat liver mitochondria stimulates transcription of mitochondrial DNA[J].Nucleic Acids Res,2003,31(17):5039-5047.
    [19]李海霞,鲁艳明,温冬雪,等.凋亡诱导因子在宫颈癌组织中的表达及意义[J].中国医科大学学报,2009,38(4):268-273.
    [20]Wen Z,Lei Z,Jin-An M,et al.The inhibitory role of miR-214in cervical cancer cells through directly targeting mitochondrial transcription factor A(TFAM)[J].Eur J Gynaecol Oncol,2014,35(6):676-682.
    [21]朱玲,王祥喜,李雪梅.TRAIL诱导肿瘤细胞凋亡的分子机制及其在肿瘤生物治疗中的应用前景[J].生物物理学报,2012,28(6):448-456.
    [22]Wang F,Liu M,Li X,et al.MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells[J].FEBS Lett,2013,587(5):488-495.
    [23]Yang Z,Chen S,Luan X,et al.MicroRNA-214 is aberrantly expressed in cervical cancers and inhibits the growth of He La cells[J].IUBMB Life,2009,61(11):1075-1082.
    [24]Ranjan K,Pathak C.Expression of c FLIP Determines the Basal Interaction of Bcl-2 with Beclin-1 and Regulates p53 Dependent Ubiquitination of Beclin-1 During Autophagic Stress[J].J Cell Biochem,2016,117(8):1757-1768.
    [25]Srinivas KP,Viji R,Dan VM,et al.DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by upregulating p38 MAP kinase[J].Oncotarget,2016,7(17):24154-24171.
    [26]张有为,王锐,宋海珠.非小细胞肺癌相关抑癌基因甲基化谱的研究[J].医学研究生学报,2010,23(7):713-720.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700